BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 33143664)

  • 1. A clear cancer cell line (150057) derived from human endometrial carcinoma harbors two novel mutations.
    Chang YH; Ding DC
    BMC Cancer; 2020 Nov; 20(1):1058. PubMed ID: 33143664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and characterization of a cell line (HCH-1) originating from a human clear cell carcinoma of the ovary.
    Yamada T; Hattori K; Satomi H; Okazaki T; Mori H; Hirose Y
    J Ovarian Res; 2016 Jun; 9(1):32. PubMed ID: 27259990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular alterations in endometrial and ovarian clear cell carcinomas: clinical impacts of telomerase reverse transcriptase promoter mutation.
    Huang HN; Chiang YC; Cheng WF; Chen CA; Lin MC; Kuo KT
    Mod Pathol; 2015 Feb; 28(2):303-11. PubMed ID: 25081752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analysis of the tyrosine kinome in serous and clear cell endometrial cancer uncovers rare somatic mutations in TNK2 and DDR1.
    Rudd ML; Mohamed H; Price JC; O'Hara AJ; Le Gallo M; Urick ME; ; Cruz P; Zhang S; Hansen NF; Godwin AK; Sgroi DC; Wolfsberg TG; Mullikin JC; Merino MJ; Bell DW
    BMC Cancer; 2014 Nov; 14():884. PubMed ID: 25427824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment and characterization of VOA1066 cells: An undifferentiated endometrial carcinoma cell line.
    Wang Y; Tao VL; Shin CY; Salamanca C; Chen SY; Chow C; Köbel M; Ben-Neriah S; Farnell D; Steidl C; Mcalpine JN; Gilks CB; Huntsman DG
    PLoS One; 2020; 15(10):e0240412. PubMed ID: 33052929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic mutation profiles of clear cell endometrial tumors revealed by whole exome and targeted gene sequencing.
    Le Gallo M; Rudd ML; Urick ME; Hansen NF; Zhang S; ; Lozy F; Sgroi DC; Vidal Bel A; Matias-Guiu X; Broaddus RR; Lu KH; Levine DA; Mutch DG; Goodfellow PJ; Salvesen HB; Mullikin JC; Bell DW
    Cancer; 2017 Sep; 123(17):3261-3268. PubMed ID: 28485815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular changes preceding endometrial and ovarian cancer: a study of consecutive endometrial specimens from Lynch syndrome surveillance.
    Niskakoski A; Pasanen A; Lassus H; Renkonen-Sinisalo L; Kaur S; Mecklin JP; Bützow R; Peltomäki P
    Mod Pathol; 2018 Aug; 31(8):1291-1301. PubMed ID: 29588532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted mutation analysis of endometrial clear cell carcinoma.
    Hoang LN; McConechy MK; Meng B; McIntyre JB; Ewanowich C; Gilks CB; Huntsman DG; Köbel M; Lee CH
    Histopathology; 2015 Apr; 66(5):664-74. PubMed ID: 25308272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
    Sato N; Tsunoda H; Nishida M; Morishita Y; Takimoto Y; Kubo T; Noguchi M
    Cancer Res; 2000 Dec; 60(24):7052-6. PubMed ID: 11156411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-existing TP53 and ARID1A mutations promote aggressive endometrial tumorigenesis.
    Reske JJ; Wilson MR; Holladay J; Siwicki RA; Skalski H; Harkins S; Adams M; Risinger JI; Hostetter G; Lin K; Chandler RL
    PLoS Genet; 2021 Dec; 17(12):e1009986. PubMed ID: 34941867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The genetic landscape of endometrial clear cell carcinomas.
    DeLair DF; Burke KA; Selenica P; Lim RS; Scott SN; Middha S; Mohanty AS; Cheng DT; Berger MF; Soslow RA; Weigelt B
    J Pathol; 2017 Oct; 243(2):230-241. PubMed ID: 28718916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and characterization of a cell line (OMC-9) originating from a human endometrial stromal sarcoma.
    Kakuno Y; Yamada T; Mori H; Narabayashi I
    Hum Cell; 2008 May; 21(2):46-55. PubMed ID: 18397474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Establishment and characterization of the new cell line (EI) from a human endometrial adenocarcinoma].
    Yudate T; Isaka K; Okabe K; Takayama M
    Hum Cell; 1995 Mar; 8(1):43-8. PubMed ID: 7669752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment and characterization of a novel ovarian clear cell carcinoma cell line, TU-OC-2, with loss of ARID1A expression.
    Sato S; Itamochi H; Oumi N; Chiba Y; Oishi T; Shimada M; Sato S; Chikumi J; Nonaka M; Kudoh A; Komatsu H; Harada T; Sugiyama T
    Hum Cell; 2016 Oct; 29(4):181-7. PubMed ID: 26960408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic mutations of the PTEN/NMAC1 gene associated with frequent chromosomal loss detected using comparative genomic hybridization in endometrial cancer.
    Hirai Y; Tanaka N; Furuta R; Kawaguchi T; Sakamoto M; Shirahama S; Noda T
    Gynecol Oncol; 2001 Oct; 83(1):81-8. PubMed ID: 11585417
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Kawahara N; Yamada Y; Kobayashi H
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dedifferentiated carcinoma with clear cell carcinoma of the endometrium: A case report.
    Lee SE; Park HY; Shim SH; Kim WY
    Pathol Int; 2017 Sep; 67(9):472-476. PubMed ID: 28667682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Markers of the p53 pathway further refine molecular profiling in high-risk endometrial cancer: A TransPORTEC initiative.
    Edmondson RJ; Crosbie EJ; Nickkho-Amiry M; Kaufmann A; Stelloo E; Nijman HW; Leary A; Auguste A; Mileshkin L; Pollock P; MacKay HJ; Powell ME; Bosse T; Creutzberg CL; Kitchener HC
    Gynecol Oncol; 2017 Aug; 146(2):327-333. PubMed ID: 28511869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining the extent of cables loss in endometrial cancer subtypes and its effectiveness as an inhibitor of cell proliferation in malignant endometrial cells in vitro and in vivo.
    DeBernardo RL; Littell RD; Luo H; Duska LR; Oliva E; Kirley SD; Lynch MP; Zukerberg LR; Rueda BR
    Cancer Biol Ther; 2005 Jan; 4(1):103-7. PubMed ID: 15662117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histotype-genotype correlation in 36 high-grade endometrial carcinomas.
    Hoang LN; McConechy MK; Köbel M; Han G; Rouzbahman M; Davidson B; Irving J; Ali RH; Leung S; McAlpine JN; Oliva E; Nucci MR; Soslow RA; Huntsman DG; Gilks CB; Lee CH
    Am J Surg Pathol; 2013 Sep; 37(9):1421-32. PubMed ID: 24076778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.